Regeneron Pharmaceuticals Inc. (REGN) Earnings Preview: Reports Before the Open
As seen on the 24/7 Wall St. homepage on July 30, 2026.
Regeneron reports Q2 results at 6:30 AM ET with investors watching Eylea HD's grip on the wet AMD market against Roche's Vabysmo and the growing shadow of Medicare drug price negotiations on its pipeline.
Mentioned: REGN